MLYS vs NKTR: stock comparison and AI forecast
Mineralys Therapeutics, Inc. (MLYS) and Nektar Therapeutics (NKTR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MLYS Mineralys Therapeutics, Inc.
- Market Cap
- $1.35B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NKTR Nektar Therapeutics
- Market Cap
- $1.23B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MLYS and NKTR have similar market capitalizations ($1.35B and $1.23B).
- MLYS carries 0.25 times debt per unit of equity, against 0.21 times for NKTR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MLYS | NKTR |
|---|---|---|
| Market Cap | $1.35B | $1.23B |
| P/B Ratio | 2.67x | 1.37x |
| EPS | $-4.60 | $-6.23 |
| Book Value/Share | $5.70 | $26.45 |
| Revenue/Share | – | $1.60 |
| FCF/Share | – | $-6.85 |
Profitability & Margins
| Metric | MLYS | NKTR |
|---|---|---|
| ROE | -73.4% | -17.4% |
| ROA | -58.7% | -14.3% |
| ROIC | -67.5% | -13.7% |
| Operating Margin | – | -257.8% |
| Net Margin | – | -287.8% |
| EBT Margin | – | -287.7% |
| Tax Rate | – | -0.0% |
Financial Health
| Metric | MLYS | NKTR |
|---|---|---|
| Current Ratio | 11.83x | 10.42x |
| D/E Ratio | 0.25x | 0.21x |
| Financial Leverage | 1.25x | 1.21x |
| Interest Coverage | – | -120.1x |
| Working Capital | $575M | $668M |
Cash Flow
| Metric | MLYS | NKTR |
|---|---|---|
| Operating Cash Flow | -$153M | -$234M |
| Free Cash Flow | – | -$234M |
| Capital Spending | – | -$240K |
| FCF/Sales | – | -428.7% |
| CapEx/Sales | – | 0.5% |
Operational Efficiency
| Metric | MLYS | NKTR |
|---|---|---|
| Asset Turnover | – | 0.05x |
Income Statement
| Metric | MLYS | NKTR |
|---|---|---|
| Total Revenue | – | $55M |
| Operating Income | -$390M | -$141M |
| Net Income | -$370M | -$157M |
| R&D Expense | $293M | $132M |
| Cost of Goods Sold | – | $0.00M |
Dividend & Shareholder Information
| Metric | MLYS | NKTR |
|---|---|---|
| Shares Outstanding | 88M | 34M |
MLYS vs NKTR: stock comparison and AI forecast
Which is bigger, MLYS or NKTR?
MLYS and NKTR have similar market capitalizations ($1.35B and $1.23B).
Which one does Intratio's AI model rank higher, MLYS or NKTR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.